142 related articles for article (PubMed ID: 36545200)
1. Drug repositioning for SARS-CoV-2 by Gaussian kernel similarity bilinear matrix factorization.
Wang Y; Xiang J; Liu C; Tang M; Hou R; Bao M; Tian G; He J; He B
Front Microbiol; 2022; 13():1062281. PubMed ID: 36545200
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Potential Therapeutic Drugs for COVID-19 Through Logistic Matrix Factorization With Kernel Diffusion.
Tian X; Shen L; Gao P; Huang L; Liu G; Zhou L; Peng L
Front Microbiol; 2022; 13():740382. PubMed ID: 35295301
[TBL] [Abstract][Full Text] [Related]
3. Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction.
Peng L; Tian X; Shen L; Kuang M; Li T; Tian G; Yang J; Zhou L
Front Genet; 2020; 11():577387. PubMed ID: 33193695
[TBL] [Abstract][Full Text] [Related]
4. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
Su X; Hu L; You Z; Hu P; Wang L; Zhao B
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
[TBL] [Abstract][Full Text] [Related]
5. VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares.
Shen L; Liu F; Huang L; Liu G; Zhou L; Peng L
Comput Biol Med; 2022 Jan; 140():105119. PubMed ID: 34902608
[TBL] [Abstract][Full Text] [Related]
6. Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures.
Peng L; Shen L; Xu J; Tian X; Liu F; Wang J; Tian G; Yang J; Zhou L
Sci Rep; 2021 Mar; 11(1):6248. PubMed ID: 33737523
[TBL] [Abstract][Full Text] [Related]
7. Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization.
Wang J; Wang C; Shen L; Zhou L; Peng L
Front Genet; 2021; 12():749256. PubMed ID: 34691157
[TBL] [Abstract][Full Text] [Related]
8. Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19.
Tang X; Cai L; Meng Y; Xu J; Lu C; Yang J
Front Immunol; 2020; 11():603615. PubMed ID: 33584672
[TBL] [Abstract][Full Text] [Related]
9. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.
Kadioglu O; Saeed M; Greten HJ; Efferth T
Comput Biol Med; 2021 Jun; 133():104359. PubMed ID: 33845270
[TBL] [Abstract][Full Text] [Related]
11. Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
Choudhury M; Dhanabalan AK; Goswami N
J Cell Biochem; 2022 Feb; 123(2):347-358. PubMed ID: 34741481
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
[TBL] [Abstract][Full Text] [Related]
13. In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2.
Deshpande RR; Tiwari AP; Nyayanit N; Modak M
Eur J Pharmacol; 2020 Nov; 886():173430. PubMed ID: 32758569
[TBL] [Abstract][Full Text] [Related]
14. Repositioning of histamine H
Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
[TBL] [Abstract][Full Text] [Related]
15. Weighted hypergraph learning and adaptive inductive matrix completion for SARS-CoV-2 drug repositioning.
Ma Y; Zhong J; Zhu N
Methods; 2023 Nov; 219():102-110. PubMed ID: 37804962
[TBL] [Abstract][Full Text] [Related]
16. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
Mishra J; Prasun C; Sahoo PK; Nair MS
Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
[TBL] [Abstract][Full Text] [Related]
18. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.
Jalalvand A; Khatouni SB; Najafi ZB; Fatahinia F; Ismailzadeh N; Farahmand B
J Basic Clin Physiol Pharmacol; 2021 Jul; 33(1):85-95. PubMed ID: 34265888
[TBL] [Abstract][Full Text] [Related]
19.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An
Behera SK; Mahapatra N; Tripathy CS; Pati S
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):132-143. PubMed ID: 33818470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
